Stevanato Group (NYSE:STVN – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)), Briefing.com reports. Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The company had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same period in the prior year, the firm earned $0.16 EPS. Stevanato Group’s quarterly revenue was up 2.4% on a year-over-year basis. Stevanato Group updated its FY 2024 guidance to 0.517-0.539 EPS and its FY24 guidance to €0.47-0.49 EPS.
Stevanato Group Stock Up 0.8 %
Shares of NYSE STVN traded up €0.17 ($0.19) during trading hours on Thursday, hitting €22.72 ($24.97). 383,800 shares of the company’s stock were exchanged, compared to its average volume of 510,737. Stevanato Group has a 1-year low of €16.56 ($18.20) and a 1-year high of €34.73 ($38.16). The company has a debt-to-equity ratio of 0.19, a current ratio of 1.74 and a quick ratio of 1.13. The company’s 50-day moving average price is €19.66 and its 200-day moving average price is €20.31.
Wall Street Analyst Weigh In
STVN has been the subject of a number of analyst reports. Citigroup reduced their price target on Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Morgan Stanley reduced their price target on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating for the company in a research report on Monday, July 15th.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- What Do S&P 500 Stocks Tell Investors About the Market?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Stock Analyst Ratings and Canadian Analyst Ratings
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
